ClinicalTrials.gg
Drug

Suzetrigine clinical trials

Also written VX-548 and Journavx.

studies test it
57
open now
30
in phase 3
14
first study started
2021

How each study uses suzetrigine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the suzetrigine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
30 Jan 2025 · JOURNAVX · NDA 219209 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Suzetrigine
45
SUZ
13
Suzetrigine (SUZ)
3
Suzetrigine (Journavx)
3

Brand

Journavx
15

Development codes

VX-548
26

Studies by the year they started

54 studies that test it; most in 2026 (26); 3 more planned to start later

Studies that test suzetrigine, by start year
YearStudies
20212
20227
20235
20244
202510
202626

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
13
Phase 2
4
Phase 3
14
Phase 4
24

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 27 · Other 30

Vertex Pharmaceuticals Incorporated (26) · University of California, San Diego (2) · University of California, Irvine (2) · University of California, Los Angeles (2) · Hospital for Special Surgery, New York (2) · Icahn School of Medicine at Mount Sinai (2) · Medical University of Vienna (1) · Mayo Clinic (1)

Often tested with

Tested in the same studies.

VX-150 (1) · VX-993 (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 18, 9 in phase 3

Studies that test suzetrigine, phase 3 first.

Studies

Open first, then newest update. How each study uses suzetrigine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 57

See all 57 studies that test suzetrigine →

As the comparator · 3 — what is tested is compared with suzetrigine

Codes

What other systems call suzetrigine · ClinicalTrials.gg INT002106

  • MeSH (NLM) C000731184suzetrigineOne source NLM
  • UNII (FDA) LOG73M21H5SUZETRIGINEConfirmed FDA, NLM, Wikidata
  • Wikidata Q123481189suzetrigineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C199115SuzetrigineOne source FDA
  • DrugBank DB18927One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.